Benign prostatic hyperplasia (BPH), the prostate gland becomes enlarged which cause urinary dysfunction. It affects the GU in three ways, histologic prostatic hyperplasia, increase in outflow resistance, and bladder muscle obstruction. This is due because prostate growth function with androgen 5 alpha dihydrotestosterone. Treatment includes: alpha 1 adrenergic receptor blockers such ,as tamulosin, which decreases sympathetic tone and relax urethral stricture, by blocking alpha 1 adrenergic receptor (Edmunds, & Mayhew 2014). 5 alpha reductase inhibitors such as finasteride are also helpful in reducing the
Benign prostatic hyperplasia (BPH), the prostate gland becomes enlarged which cause urinary dysfunction. It affects the GU in three ways, histologic prostatic hyperplasia, increase in outflow resistance, and bladder muscle obstruction. This is due because prostate growth function with androgen 5 alpha dihydrotestosterone. Treatment includes: alpha 1 adrenergic receptor blockers such ,as tamulosin, which decreases sympathetic tone and relax urethral stricture, by blocking alpha 1 adrenergic receptor (Edmunds, & Mayhew 2014). 5 alpha reductase inhibitors such as finasteride are also helpful in reducing the